RE: Chart11 Nov 2025 15:06
Alex - you also have been abusive to me several times. My track record here - declared when I bought; declared when I sold; declared my 'back-in' target. Questioned the changing of the narrative in the 25/10 RNS 'stated aim' from 'deal done' (a massive change ). Stated the business is loss making (-£2m) (and has no means of income other than an R&D credit FY24 £297k) . Flagged no patent. Flagged potential of 2 to 5 years for a patent to be granted etc All factual so far, yes? Questioned the H2 2026 cash runway position assertion. In FY24... £1.18m went on salaries for 6 staff last year, directors emoluments £724k, £1.5m costs in trade and other payables, which might well mean that they are delaying payment of these to improve position at year end and then add in operating expenses for FY25. £2.25m from Lanstead suddenly looks a little less chunky. Put simply, IMM need to hit the Jackpot or Lanstead / other are back and this time it is a death spiral.